ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 737건의 자료가 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 674 | Terminated | A Study to Evaluate the Effect of RBT-9 on Progression of COVID-19 in High-Risk Individuals (The PREVENT Study) | COVID-19 | Drug: RBT-9 (90 mg) Drug: 0.9% sodium chloride (normal saline) |
Phase 2 | Renibus Therapeutics, Inc. | INDUSTRY | 42 | All | 18 Years | New Smyrna Beach, FL, New Smyrna Beach, Florida, United States Berkley, MI, Berkley, Michigan, United States El Paso, TX, El Paso, Texas, United States Fort Worth, TX, Fort Worth, Texas, United States Houston, Houston, Texas, United States |
| 673 | Completed | A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19 | COVID-19 | Drug: Brilacidin Drug: Placebo Drug: Standard of Care (SoC) |
Phase 2 | Innovation Pharmaceuticals, Inc. | INDUSTRY | 120 | All | 18 Years ~ 80 Years | IPI Investigator Site, Winfield, Illinois, United States IPI Investigator Site, Toledo, Ohio, United States IPI Investigator Site, Barnaul, Russian Federation IPI Investigator Site, Moscow, Russian Federation IPI Investigator Site, Moscow, Russian Federation IPI Investigator Site, Moscow, Russian Federation IPI Investigator Site, Moscow, Russian Federation IPI Investigator Site, Nizniy Novgorod, Russian Federation IPI Investigator Site, Pushkin, Russian Federation IPI Investigator Site, Saint Petersburg, Russian Federation IPI Investigator Site, Saint Petersburg, Russian Federation IPI Investigator Site, Saint Petersburg, Russian Federation |
| 672 | Completed | A Study to Evaluate the Efficacy and Safety of Ivermectin in COVID-19 Prevention | COVID-19 | Drug: Ivermectin Tablets Drug: Matching placebo tablets |
Phase 2 | MedinCell S.A, Violaine Desort-Henin, DVM | INDUSTRY | 400 | All | 18 Years ~ 65 Years | Medical Center Medic Ltd., Sofia, Bulgaria |
| 671 | Active, not recruiting | A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years | SARS-CoV-2 Infection | Biological: SCTV01E Biological: Placebo |
Phase 3 | Sinocelltech Ltd. | INDUSTRY | 10000 | All | 18 Years | Guizhou center for disease control and prevention, Guiyang, Guizhou, China |
| 670 | Withdrawn | A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection | Covid19 | Drug: Xlear Nasal Spray Drug: Placebo |
Phase 3 | Larkin Community Hospital | OTHER | 0 | All | 18 Years ~ 90 Years | Larkin Community Hospital, Miami, Florida, United States |
| 669 | Unknown status | A Study to Evaluate the Efficacy, Safety and Immunogenicity of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Adults Aged 18 Years and Older (COVID-19) | COVID-19 | Biological: SARS-CoV-2 Vaccine (Vero Cells), Inactivated Biological: Placebo |
Phase 3 | Shenzhen Kangtai Biological Products Co., LTD, Beijing Minhai Biotechnology Co., Ltd | INDUSTRY | 28000 | All | 18 Years | |
| 668 | Withdrawn | A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years | SARS-CoV-2 Infection | Biological: SCTV01C Biological: SCTV01C Biological: SCTV01C Biological: SCTV01E Biological: SCTV01E Biological: SCTV01E Biological: mRNA vaccine manufactured by Pfizer or Moderna Biological: mRNA vaccine manufactured by Pfizer or Moderna Biological: mRNA vaccine manufactured by Pfizer or Moderna Biological: Sinopharm inactivated COVID-19 vaccine Biological: Sinopharm inactivated COVID-19 vaccine Biological: Sinopharm inactivated COVID-19 vaccine |
Phase 2 | Sinocelltech Ltd. | INDUSTRY | 0 | All | 12 Years |
